Request Demo
Dutch State Announces the Sale of Intravacc B.V. (The Netherlands)
03 May 2023
Vaccine
DEN HAGUE, Netherlands, May 3, 2023 /PRNewswire/ -- The State of the Netherlands, the Dutch Ministry of Health, Welfare and Sport today announces its intentions to sell 100% of the issued and outstanding shares in the capital of Intravacc B.V. through a controlled auction process.
Continue Reading
Related Documents
Preview
Source: PRNewswire
View PDF
Link to advertisement in FT of sale of Dutch Intravacc
Intravacc, located at Utrecht Science Park Bilthoven in the Netherlands, is an established independent contract development and manufacturing organization for infectious diseases and therapeutic vaccines. As an CDMO with many years of experience in the development and optimization of vaccines and vaccine technologies, Intravacc has transferred its technology world-wide for many vaccines, including polio, measles, DTP, Hib and influenza. Intravacc offers a wide range of expertise for independent vaccine development, from proof-of-concept to Phase I/II clinical studies for partners around the world, including universities, public health organizations, biotech and pharmaceutical companies.
See as appendix the advertisement.
Contact info
LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens
T: +31 6 538 16 427
E: [email protected]
Ernst & Young (EY) Strategy and Transactions, financial adviser to the Dutch State, at [email protected].
PDF: https://mma.prnewswire.com/media/2068627/Intravacc_Advertisement_FT.pdf
Logo: https://mma.prnewswire.com/media/1334670/Intravacc_Logo.jpg
SOURCE Intravacc
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.